MDSC |
Immunosuppressive function related proteins and RNA |
Tumor cells |
+ |
Tumor immunosuppression |
[119] |
MDSC |
S100A9 |
Colorectal cancer cells (Induced CAC model in BALB/c mice) |
+ |
The percentage of total T cells and their subsets in peripheral blood and the number of CD3+CD8+T cells in colorectal tissues of G-MDSCs-Exo treated CAC mice decreased, thereby weakening tumor immunity |
[120] |
MDSC |
miR-143-3p |
Lung cancer cell (Including the subcutaneous model of C57B6 mice) |
+ |
Promote the proliferation of tumor |
[121] |
MDSC |
ILs, TNF-α, etc |
CD8+T cells (MDSC derived exosomes treated C57B6 and Balb/c mice models) |
+ |
Promote apoptosis of CD8+ T cells |
[122] |
B cells |
MHCII, FasL |
CD4+T cells |
|
Immunosuppression |
[125] |
B cells |
CD19 |
Tumor cells (C57BL/6J, NSG mice, Adora2aflox/flox, Rab27afl/fl, Hif1afl/fl, Cd19-cre mice) |
+ |
The production of adenosine inhibits the proliferation and killing ability of CD8+ T cells |
[126] |
B cells |
miR-330-3p |
Non mesenchymal ovarian cancer cells (Models of subcutaneous tumorigenesis and peritoneal metastasis) |
+ |
To promote its mesenchymal transformation |
[127] |
Mast cells |
MHC II, CD86, LFA-1 and ICAM-1 |
B and T cells |
|
Induced its proliferation and cytokine production |
[130] |
Mast cells |
Exogenous Ags and endogenous heat shock proteins |
DC cells |
|
Promote its mature to play the role of antigen presentation |
[131] |
Mast cells |
OX40L |
CD4+T cells |
|
Promote proliferation and differentiation |
[132] |
Mast cells |
KIT |
Lung adenocarcinoma cell |
+ |
Promote the proliferation of tumor cells |
[133] |
Neutrophils |
miR-4466 |
Brain tumor cells (athymic nude mice, BALB/c mice) |
+ |
Promote tumor cell stem and metastasis |
[136] |